computer aided formulation development

10,154 views 33 slides May 12, 2020
Slide 1
Slide 1 of 33
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33

About This Presentation

computer adided drug design ,mpharm ,pharmaceutics.kerala university of health science


Slide Content

COMPUTER AIDED FORMULATION DEVELOPMENT : OPTIMISATION SUJITHA MARY M.PHARM(2ND SEMESETER) DEPARTMENT OF PHARMACEUTICS ST JOSEPH COLLEGE OF PHARMACY 1

CONCEPT OF OPTIMIZATION: Product formulation is often considered as an art, the formulator’s experience and creativity of converting raw materials into product   The pharmaceutical scientist has the responsibility to choose and combine ingredients that will result in a formulation, whose result or responses are of expected value. Before the advances in the research technique and availability of computes, the formulation research was based on experience and experimenting by trial and error .  In a pharmaceutical formulation and development various formulation trials have to be done to obtain a good process and a suitable formulation.   2

In the trial and error method, a lot of formulations have to be done to get a conclusion. These can be minimized with the help of optimization technique . The word “optimize” is defined as: To make as PERFECT, EFFECTIVE, or FUNCTIONAL as possible. The optimization techniques provide both a depth of understanding and an ability to explore and defend ranges for formulation and processing factors. It is at this point that optimization can become a useful tool to quantitate a formulation which is qualitatively determined. Optimization is used often in pharmacy with respect to formulation and to processing . 3

Optimization is defined as follows : “Choosing the best element from some set of available alternatives”. It is the process of finding the best way of using the existing resources while taking in to the account of all the factors that influences decisions in any experiment. The objective of designing quality formulation is achieved by various Optimization techniques like DoE (Design of Experiment). The term FbD (Formulation by Design) & QbD (Quality by Design) indicates that quality in the product can be built by using various techniques of DOE (Design of Experiment ). 4

Quality by Design ( QbD ) The pharmaceutical Quality by Design ( QbD ) is a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management. Quality by Design ( QbD ) is emerging to enhance the assurance of safe, effective drug supply to the consumer, and also offers promise to significantly improve manufacturing quality performance. The Quality of the pharmaceutical product can be evaluated by in vivo or in vitro performance tests “ QbD ” assures in vitro product performance and In vitro product performance provides assurance of in vivo product performance. 5

DOE(Design of Experiment) It is a mathematical tool for systematically planning and conducting scientific studies that change experimental variables together in order to determine their effect on a given response . It makes controlled changes to input variables in order to gain maximum amounts of information on cause and effect relationships with a minimum sample size for optimizing the formulation. In Optimization Method ,various types of Model used from preliminary screening of factors to select their level and for finally study of their effect .so it’s depend upon the formulator to choose a suitable model for study and help in minimizing the experimenting time. 6

Define the Problem & Select the variables Screening the factor and their level Design the Formulation according to Model Used Analyse the Result Select the Check Point Formulation Validate and Optimize the Model (Basic Flow Chart for using DOE and optimizing the formulation) 7

Why optimization is necessary? Reduce the cost Save the time Safety and reduce the error Reproducibility Innovation and efficacy 8

OPTIMISATION PARAMETERS DEPT OF PHARMACEUTICS. NGSMIPS 9

DEPT OF PHARMACEUTICS. NGSMIPS 10

11

EXPERIMENTAL DESIGN Experimental design is a statistical design that prescribes or advises a set of combination of variables. The number and layout of these design points within the experimental region, depends on the number of effects that must be estimated. Depending on the number of factors, their levels, possible interactions and order of the model, various experimental designs are chosen. 12

Factorial Designs Factorial designs (FDs) are very frequently used response surface designs. These are the designs of choice for simultaneous determination of the effects of several factors & their interactions . Used in experiments where the effects of different factors or conditions on experimental results are to be elucidated . Two types Full factorial- Used for small set of factors Fractional factorial- Used for optimizing more number of factors DEPT OF PHARMACEUTICS. NGSMIPS 13

Full Factorial Designs Involves study of the effect of all factors(n) at various levels(x) including the interactions among them with total number of experiments as X n . If the number of levels is the same for each factor in the optimization study, the FDs are said to be symmetric, whereas in cases of a different number of levels for different factors, FDs are termed asymmetric.'' Fractional Factorial Design (FFD) Fractional factorial design is generally used for screening of factor. This design has low resolution due to less number of run. It is used to examine multiple factors efficiently with fewer runs than corresponding full factorial design. DEPT OF PHARMACEUTICS. NGSMIPS 14

Types of fractional factorial designs Homogenous fractional Mixed level fractional Box-Hunter Plackett - Burman Taguchi Latin square 15

Homogenous fractional Useful when large number of factors must be screened. Mixed level fractional Useful when variety of factors need to be evaluated for main effects and higher level interactions can be assumed to be negligible. Box-hunter Fractional designs with factors of more than two levels can be specified as homogenous fractional or mixed level fractional. 16

Plackett - Burman It is a popular class of design. These designs are very efficient screening designs when only the main effects are of interest. These are useful for detecting large main effects economically ,assuming all interactions are negligible when compared with important main effects. Used to investigate n-1 variables in n experiments proposing experimental designs for more than seven factors and especially for n*4 experiments. 17

Taguchi It is similar to PBDs. It is a method of ensuring good performance in the development of products or processes." It allows estimation of main effects while minimizing variance . Latin square They are special case of fractional factorial design where there is one treatment factor of interest and two or more blocking factors. 2. Screening Designs It is used for identify the important factor and their level which affect the Quality of Formulation. Screening Designs generally support only the linear responses. 18

3. Response Surface Designs These designs are used when we required exact image of response, estimating interaction and even quadratic effects. Response surface designs generally support non linear and quadratic response and capable of detecting curvatures . Two most common designs generally used in this response surface modelling are Central composite designs Box- Behnken designs 19 Response surface representing the relationship between the independent variables X 1 and X 2 and the dependent variable Y.

Central Composite Design (Box-Wilson design) This type contains an embedded factorial or fractional factorial design with centre points that is augmented with the group of ‘star points’. The star points represent new extreme value (low & high) for each factor in the design A CCD has three groups of design points : ( a) Two-level factorial or fractional factorial design points (b) Axial points (sometimes called "star" points) (c) Center points 20

b. Box- behnken Design They do not contain embedded factorial or fractional factorial design. A specially made design, it requires only three levels for each factor -l, 0 and +1. These designs for three factors with circled point appearing at the origin and possibly repeated for several runs . It is economical than CCD because it requires less number of Trial . 21

4. Mixture Design Here the fraction cannot be negative, and sum of the fractions of the components should be equal to one. Hence, they have often been described as the experimental design for formulation optimization 22

23 VARIOUS SCREENING AND RESPONSE SURFACE DESIGNS

OPTIMIZATION TECHNIQUES The techniques for optimization are broadly divided into two categories: (A) Simultaneous method : Experimentation continues as optimization study proceeds. E.g. Evolutionary Operations Method Simplex Method (B) Sequential method : Experimentation is completed before optimization takes place. E.g. Classic Mathematical Method Search Method In case (B), the formulator has to obtain the relationship between any dependent variable and one or more independent variables. This include two approaches: Theoretical Approach and Empirical Approach . DEPT OF PHARMACEUTICS. NGSMIPS 24

Evolutionary Operations (EVOP) It is a method of experimental optimization. Small changes in the formulation or process are made (i.e. repeats the experiment so many times) and statistically analyzed whether it is improved. It continues until no further changes takes place i.e., it has reached optimum-the peak The result of changes are statistically analyzed. DEPT OF PHARMACEUTICS. NGSMIPS 25 A. SIMULTANEOUS METHOD

Example In this example, A formulator can change the concentration of binder and get the desired hardness. DEPT OF PHARMACEUTICS. NGSMIPS 26 TABLET HARDNESS RESPONSE HOW CAN WE GET HARDNESS BY CHANGING THE CONCENTRATION OF BINDER

Simplex Method(simplex Lattice) It is an experimental techniques & mostly used in analytical rather than formulation & processing. Simplex is a geometric figure that has one more point than the number of factors. Eg - If 2 independent variables then simplex is represented as triangle. The strategy is to move towards a better response by moving away from worst response. Applied to optimize capsules, direct compression of tablet, liquid systems (physical stability) . It is also called as Downhill Simplex / Nelder -Mead Method. DEPT OF PHARMACEUTICS. NGSMIPS 27

B. SEQUENTIAL METHOD DEPT OF PHARMACEUTICS. NGSMIPS 28 Classic Mathematical Model Algebraic expression defining the dependence of a response variable on the independent variables Two approaches: Theoretical approach- If theoretical equation is known , no experimentation is necessary. Empirical or experimental approach – With single independent variable formulator experiments at several levels.

Search Methods It is defined by appropriate equations. It do not require continuity or differentiability of function It is applied to pharmaceutical system. The response surface is searched by various methods to find the combination of independent variables yielding an optimum. It takes five independent variables into account and is computer assisted. DEPT OF PHARMACEUTICS. NGSMIPS 29

The system selected here a tablet formulation. The five independent variables or formulation factors selected for the study are shown below: DEPT OF PHARMACEUTICS. NGSMIPS 30

The dependent variables are listed below: DEPT OF PHARMACEUTICS. NGSMIPS 31

CONCLUSION The area of optimization is vary vast and its applications in all areas of pharmaceutical science. Optimization helps in getting optimum product with desired bioavailability criteria as well as mass production . Optimization techniques are help full in reducing the cost of product by minimizing the number of experimental trials during formulation development. 32

REFERENCE G S Banker, CT Rhodes. Modern Pharmaceutics, Ed 4. Marcel Dekker. New York. 2002; p: 607-24 Djuris J.Computer aided application in pharmaceutical technology.Wood head publishers . New delhi , 2013 ;P: 17-24 33